Insights
Videos
Pricing
About us
Contact us
Noxopharm (ASX: NOX) has locked in a $1.5 million placement and launched a $1.0 million share plan to fund its lupus skin study, FDA-guided Phase II preparation and cancer research, with convertible notes proposed to convert into shares.
FortifAI (ASX: FTI) has released NOL8 Version 2.0 ahead of schedule, advancing its AI data infrastructure commercialisation strategy through independent performance testing, leadership appointments and preparations for enterprise customer adoption.
Star Combo Pharma (ASX: S66) will ask shareholders on 24 November to approve a constitution change enabling share buybacks, re-elect a director and adopt its remuneration report, while its governance statement reveals a lean, small-board structure.
4DMedical (ASX: 4DX) faces a first strike on pay and a failed incentive vote after its AGM, while short sellers drove a sharp sell-off. Strong revenue growth now meets rising investor scrutiny over cash burn.
DevEx Resources (ASX: DEV) has advanced uranium exploration at its Nabarlek Project, completing 40 drill holes across four targets and identifying further mineralisation indicators, while strengthening its broader exploration strategy and maintaining a solid cash position.
Metal Hawk (ASX: MHK) has paired a $1.2 million placement with high-grade drilling at its Numbat lode, while a new shear-hosted gold style hints at a larger system ahead of diamond drilling and its November AGM.
Are you sure you want to log out from your account?